TickerFactsScreenerDevelopers

Atara Biotherapeutics, Inc. (ATRA) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2012: $4.21M2013: $51.62M2014: $21.90M2015: $23.75M2016: $47.97M2017: $79.22M2018: $60.70M2019: $74.32M2020: $200.40M2021: $106.08M2022: $92.94M2023: $25.84M2024: $25.03M2025: $8.48M$8.48M
2012Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$8.48M-66.1%
2024$25.03M-3.1%
2023$25.84M-72.2%
2022$92.94M-12.4%
2021$106.08M-47.1%
2020$200.40M+169.7%
2019$74.32M+22.4%
2018$60.70M-23.4%
2017$79.22M+65.2%
2016$47.97M+102.0%
2015$23.75M+8.4%
2014$21.90M-57.6%
2013$51.62M+1126.9%
2012$4.21M—